D202005 – Automated learning for characterization in flow imaging of markers of therapeutic efficacy in patients with sickle cell disease treated by gene therapy Pierre Buffet
D202006 – Measurement of the hemoglobin mass of sickle cell patients treated by gene therapy using the “CO rebreathing” method Pablo Bartolucci
MA202002 – Diagnosis and monitoring of pre and post gene therapy patients at the Biological Resource Center (CRB-DNA) of Necker Hospital Marie-alexandra Alyanakian
T202002 – Optimizing Hematopoietic Stem and Progenitor Cells (HSPC) genetic engineering in inflammatory context Dr. Emmanuelle Six
T202003 – Pre-clinical model for the use of universal MAIT cells carrying a chimeric receptor (CAR-MAIT) Sophie Caillat Zucman
D201906 – Cellular characterization of the red blood cells deformability of sickle cell patients treated with gene therapy Dr. Pierre Buffet
T201905 – Use of universal MAIT cells carrying a chimeric receptor (CAR-MAIT) in an allogenic context Dr. Sophie Caillat-Zucman
A201901- Pushing forward cochlear gene therapy with a high speed and large field of view confocal microscope Pr. Christine Petit
D201905 – Intravascular hemolysis assessment in Sickle Cell Patients treated with Gene Therapy Pr. Pablo Bartolucci
